| 询价 | |
| V80302-0.1 | |
|
|
|
|
|
|
|
|
|
| Specificity | SARS-CoV-2 Spike Protein S1 subunit and its RBD domain |
| Clone ID | R323IgM |
| Isotype | Recombinant human IgM |
| Production | Cultured in vitro under conditions free from animal-derived components |
| Purification | Affinity chromatography |
| Concentration | ≥ 2mg/ml |
| Formulation | PBS, pH 7.2, containing 0.02% sodium azide. |
| Storage | For long term storage, aliquot and store at -25°C~-15°C or below. Avoid repeated freezing and thawing cycles. |
| Note | GenScript can customize this product per customer's request including product size, buffer components, etc. |
| ELISA |
»
| Target Background | SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 neutralizing antibodies. |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
